WELL Health Technologies Corp. (TSE:WELL - Get Free Report) rose 0.5% on Tuesday . The stock traded as high as C$6.64 and last traded at C$6.49. Approximately 651,875 shares changed hands during mid-day trading, a decline of 22% from the average daily volume of 835,970 shares. The stock had previously closed at C$6.46.
Analysts Set New Price Targets
WELL has been the topic of a number of recent research reports. TD Securities lifted their target price on WELL Health Technologies from C$8.00 to C$8.50 in a research report on Tuesday, December 17th. Raymond James boosted their price objective on WELL Health Technologies from C$10.00 to C$11.00 in a research report on Tuesday, December 17th. Royal Bank of Canada upped their target price on WELL Health Technologies from C$7.00 to C$8.50 in a research note on Tuesday, January 7th. Scotiabank lifted their price target on shares of WELL Health Technologies from C$6.00 to C$7.00 in a research note on Monday, December 16th. Finally, Ventum Financial increased their price objective on shares of WELL Health Technologies from C$7.50 to C$8.00 in a research note on Thursday.
Check Out Our Latest Research Report on WELL
WELL Health Technologies Price Performance
The company has a 50-day moving average of C$6.61 and a 200 day moving average of C$5.30. The company has a debt-to-equity ratio of 41.57, a quick ratio of 1.02 and a current ratio of 1.25. The firm has a market cap of C$1.48 billion, a P/E ratio of 10.40, a P/E/G ratio of -1.93 and a beta of 1.20.
WELL Health Technologies Company Profile
(
Get Free Report)
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.
See Also
Before you consider WELL Health Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and WELL Health Technologies wasn't on the list.
While WELL Health Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
